SERETIDE MDI 50/25 Price

Overview

Welcome to Dwaey, specifically on SERETIDE MDI 50/25 Inhaler/Aerosol page.
This medicine contains an important and useful components, as it consists of Fluticasone propionate, Salmeterol (as xinafoate).
SERETIDE MDI 50/25 is available in the market in concentration 50mcg, 25mcg/Dose and in the form of Inhaler/Aerosol.

GLAXO WELLCOME PRODUCTION is the producer of SERETIDE MDI 50/25 and it is imported from FRANCE, The most popular alternatives of SERETIDE MDI 50/25 are listed downward .

Mode Of Action

Salmeterol, a long acting beta 2-agonist which acts locally in the lung to mediate bronchodilation. Fluticasone, a corticosteroid with mainly glucocorticoid activity, reduce symptoms and exacerbations of asthma.

Indication

• Chronic Asthma
• COPD

Precaution

Pulmonary TB, severe cardiovascular disorders, heart rhythm abnormalities, DM, thyrotoxicosis, hypokalaemia. Patients at risk of decreased bone mineral content (e.g. smoking, old age, sedentary lifestyle, poor nutrition, family history of osteoporosis or long term use of drugs that may decrease bone mass (e.g. anticonvulsants and corticosteroids). Do not stop therapy abruptly; therapy should be down titrated. Advise patient to rinse mouth after inhalation. Monitor height of children on prolonged therapy. Pregnancy, lactation.

Side Effects

• >10% Upper respiratory tract infection (21-27%)
• Headache (12-21%)
• Pharyngitis (10-13%) 1-10% Candidiasis
• nonspecific site (0-10%)
• Throat irritation (7-9%)
• Musculoskeletal pain (2-9%)
• Bronchitis (2-8%)
• Upper respiratory inflammation (4-7%)
• Viral respiratory infections (4-6%)
• Nausea or vomiting (4-6%)
• Cough (3-6%)
• Sinusitis (4-5%)
• Hoarseness or dysphonia (2-5%)
• Fever (3-4%)
• Diarrhea (2-4%)
• Gastrointestinal (GI) discomfort or pain (1-4%)
• Oral candidiasis (1-4%)
• Muscle cramps or spasms (3%)
• Malaise or fatigue (2-3%)
• Viral GI infections (0-3%) Potentially Fatal: Paradoxical bronchospasm.

Contra indication

Not for primary treatment of status asthmaticus or other acute attacks of asthma. Severe hypersensitivity to milk proteins.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks